View Report Details Global Radiation Therapy Market Report ----------------------------------------2016
View Report Details Executive Summary Radiation depicts the way energy moves from one place to another. One of the top advancements in the field of radiotherapy has been the development of proton treatment as well development of linear accelerators. Proton treatment, likewise called proton beam treatment, is a kind of radiation treatment that uses protons instead of x-beams to treat disease. It is a very precise strategy for radiotherapy which is suitable for all patients irrespective of their age, mostly relying upon conclusion. A linear accelerator (LINAC) customizes high energy x-rays to conform to a tumor’s shape and destroy cancer cells while sparing surrounding normal tissue. Proton treatment industry is predominantly focused in the Americas; particularly in the North America. In the recent couple of years, it has been watched that the innovation is currently being received at a quick pace by authorities of the European and Asian economies. The innovation around proton treatment has additionally made advances in different corners of the world all on account of the growing incomes and enthusiasm of governments in its headway. A number of factors driving the development of radiation treatment are expanding number of cancer cases around the world, developing inclination for non-invasive methods and mechanical advancements. Different variables like maturing population additionally advance the utilization of proton treatment. Key trending innovations like pencil bar scanning hold the possibility to hoist the capacity to treat the very intricate tumors, while leaving solid tissue and basic structures untouched. This report assesses the global radiation therapy market along with major regional markets. The top companies having a vicious competition with each other and dominating the industry are- Varian Medical, Elekta, and Accuray Inc. These players are being profiled in the report alongside their key financials and business strategies.
Radiation is intended to kill cancer cells by damaging their DNA either directly or indirectly. The clinical goal of radiation oncology is to deliver as high a dose of radiation to the cancer, while also limiting the amount of exposure to the surrounding healthy tissue. Global Radiation Therapy Equipment Market (2009-2015E)
n ilo S$B U
%
The worldwide radiation therapy equipment market was valued at US$xx billion in 2014, denoting y/y growth of around xx%. The market is estimated to be worth US$xx billion for the year 2015, with growth of just xx%. While in the year 2015, there were approximately xx to xx linear accelerators, estimates suggest that augmented by the rising number of cancer cases worldwide, by the end of 2035, nearly 2xx0 accelerators would be required for radiation therapy treatments. The market share in Europe and Asian region in 2010 was xx0% and xx%, respectively, these shares for the year ended 2015 are estimated to be xx% and xx% respectively. 2009
2010
2011 2012 Revenue
2013
2014 2015E YoY Growth
Global Radiotherapy Capacity Gaps (2015/2035E)
Radiation Therapy Penetration by Region (2014) Netherlands
Radiation Technologists
Australia Singapore
Medical Physicsts
Sw eden UK
Radiation Oncologists
Italy Japan
Linear Accelerators
Mexico Russian Federation
Radiotherapy Departments
Philippines
2015
GAP
2035
Algeria %
A linear accelerator (LINAC) customizes high energy x-rays to conform to a tumor’s shape and destroy cancer cells while sparing surrounding normal tissue. It features several built-in safety measures to ensure that it will not deliver a higher dose than prescribed. Global Linear Accelerator Systems Market Value (2011-2015E)
• As of 2014, the market value of global linear accelerators reached US$xx4 billion and demand of linear accelerators is expected to continue to increase in the near future with an estimate of US$xx billion for the year ended 2015.
n ilo B S$ U
• Regional allocation of linear accelerators worldwide reported the view that the largest number of linear accelerators are found in the US & Canada combined together (xx%), followed by the second largest number of accelerators in the Asian economies. Accelerators in European countries together accounted for 20% share followed by only xx% of Oceania countries.
2011
2012
2013
2014
2015E
• The accelerators range between xx9 per million of the US/ Canadian population as against xx in the European market. The number of LINACs available per million populations the Asian and the African region is estimated to be xx and 0xxrespectively.
Linear Accelerators Volume Share by Region (2014)
Volume of LINACs by Region (2014)
US / Canada, 4355
at u P n ilo erM 'sp C A LIN
Europe, 2581
Africa Russia
Proton therapy market can be divided into two segments, namely, Equipment and Services. Proton Therapy Patients Treatment Cumulative Volume, North America (2009/2014)
In the North American market, cumulative patient volume increased at a CAGR of xx% for the period spanning 2009 to 2015, i.e. from xxx to xx. In the European market, cumulative patient volume increased at a CAGR of xx% for the period 2009-2014. In absolute terms, cumulative patient volume increased from xx in 2009 to xx in 2014.
s n fP ro b lativeN m u C
The global proton therapy market was valued at US$xx million in 2013. However, the market increased to US$xx million by the end of the year 2014, registering a YoY growth of approximately xx%. 2009
2010
2011
2012
2013
2014
Global Proton Therapy Market by Value (2013-2030)
srp o C ) iln M S$ (U m R e
sC atien P f ro b lvN m u
Proton Therapy Patients Treatment Cumulative Volume, Europe (2009/2014)
2009
2010
2011
2012
2013
2014
2014
2015E
2016E
2017E
2018E
2019E
Contact Us: Details View Report These are abridged and sanitized sample pages from the comprehensive report on the “ Radiation Therapy Market ” . To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
Vikas Gupta BD Manager
CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com
www.konceptanalytics.com